CITÓMICA
Technical University Munich
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Technical University Munich (22)
2024
-
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
Journal of Allergy and Clinical Immunology: In Practice
2023
-
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 6, pp. 1706-1717
-
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 10, pp. 3010-3020
2022
-
Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022
Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 6, pp. 1855-1865
-
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 1941-1950
-
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 1999-2012.e6
-
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 1953-1963
-
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 8, pp. 1986-1998.e2
2021
-
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
HemaSphere, Vol. 5, Núm. 11, pp. E646
2020
-
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts
Theranostics, Vol. 10, Núm. 23, pp. 10743-10768
-
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
Journal of Allergy and Clinical Immunology, Vol. 146, Núm. 2, pp. 300-306
2019
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973
-
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
The Lancet Haematology, Vol. 6, Núm. 12, pp. e638-e649
-
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 4, pp. 1125-1133.e1
2017
-
Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future
Cancer Research, Vol. 77, Núm. 6, pp. 1261-1270
2016
-
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; The American Academy of Allergy, Asthma & Immunology; And the European Academy of Allergology and Clinical Immunology
Journal of Allergy and Clinical Immunology, Vol. 137, Núm. 1, pp. 35-45
2014
-
Proposed diagnostic algorithm for patients with suspected mastocytosis: A proposal of the European Competence Network on Mastocytosis
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 69, Núm. 10, pp. 1267-1274
2013
2012
-
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal
International Archives of Allergy and Immunology, Vol. 157, Núm. 3, pp. 215-225
-
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives
Wiener Klinische Wochenschrift, Vol. 124, Núm. 23-24, pp. 807-814